Benzoxaborole antifungal
This page covers all Benzoxaborole antifungal drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Squalene epoxidase.
Targets
Marketed (1)
- Tavaborole 5% Topical Solution · Pfizer · Dermatology/Infectious Disease
Tavaborole inhibits fungal squalene epoxidase, disrupting ergosterol synthesis and causing fungal cell death.
Patent intelligence
- benzoxaborole antifungal patent landscape — aggregated cliff calendar, attackable patents, originator estates